Delivery details + Order by fax
  • PDF: Delivered by email usually within 12 to 24 UK business hours.

France Nephrology and Urology Devices Investment Opportunities
Analysis and Forecasts to 2015

  • Product Code:GMD08216
  • Publication Date:April 2009
  • Publisher:Global Markets Direct
  • Product Type: Report
  • Pages:121
Change currency
Add to my wish list > Ask a question about this product > Call now +44 20 7060 7474
Request sample

Request a sample for France Nephrology and Urology Devices Investment Opportunities

Enter the characters you see in the picture below
Captcha

France Nephrology and Urology Devices Investment Opportunities Analysis and Forecasts to 2015

This report is an essential source for in-depth information and data relating to France nephrology & urology devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the nephrology & urology devices in France

Scope

  • The report provides nephrology and urology devices information broken down into detailed categories and segments in France.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.

Reasons to buy

  • Gain a strong understanding of the nephrology and urology devices market in France.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Introduction
    • 2.1 What Is This Report About?
  • 3 Definitions of Markets Covered in This Report
    • 3.1 Nephrology and Urology Devices
    • 3.2 Incontinence Devices
      • 3.2.1 Protective garments for incontinence
      • 3.2.2 Urine Bags
      • 3.2.3 Urinary Catheters
    • 3.3 Renal Dialysis Equipment
      • 3.3.1 Hemodialysis Machines
      • 3.3.2 Peritoneal Dialysis Solutions
      • 3.3.3 Continuous Renal Replacement Therapy Machines
      • 3.3.4 Dialysis Accessories
        • 3.3.4.1 AV Fistula Needles
        • 3.3.4.2 Blood Tubing Sets
        • 3.3.4.3 Dialysis Catheters
        • 3.3.4.4 Dialyzers
    • 3.4 Lithotripters
  • 4 Healthcare Sector Review
    • 4.1 Healthcare Sector Review
    • 4.2 Healthcare Expenditure
    • 4.3 Healthcare Infrastructure
      • 4.3.1 Healthcare Personnel Data
      • 4.3.2 Healthcare Facilities Data
    • 4.4 Healthcare Policy
  • 5 Regulation System
    • 5.1 Medical Equipment Approval Process
      • 5.1.1 Classification
      • 5.1.2 Conformity Assessment Process
        • 5.1.2.1 Class I devices
        • 5.1.2.2 Class IIa devices
        • 5.1.2.3 Class IIb devices
        • 5.1.2.4 Class III devices
      • 5.1.3 Registration Fee
      • 5.1.4 Registration Period
    • 5.2 Post Market Surveillance (PMS)
  • 6 Pricing and Reimbursement
    • 6.1 Pricing and Reimbursement Policies
  • 7 Distribution Structure
    • 7.1 France Medical Equipment Distribution Structure
  • 8 Nephrology and Urology Devices In France
    • 8.1 Nephrology and Urology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • 8.2 Nephrology and Urology Devices, France, Overall Revenue ($ mn), 2000-2015
    • 8.3 Nephrology and Urology Devices, France, Category Volume (Units), 2000-2015
    • 8.4 Nephrology and Urology Devices, France, Company Share (2006-2007)
  • 9 Incontinence Devices In France
    • 9.1 Incontinence Devices Overall Revenue (2000-2015)
    • 9.2 Incontinence Devices Overall Volume (2000-2015)
    • 9.3 Incontinence Devices Average Price (2000-2015)
    • 9.4 Incontinence Devices Distribution Share (2007-2008)
    • 9.5 Incontinence Devices, France, Company Share (2006-2007)
  • 10 Lithotripters In France
    • 10.1 Lithotripters Overall Revenue (2000-2015)
    • 10.2 Lithotripters Overall Volume (2000-2015)
    • 10.3 Lithotripters Average Price (2000-2015)
    • 10.4 Lithotripters Distribution Share (2007-2008)
    • 10.5 Lithotripters, France, Company Share (2006-2007)
  • 11 Renal Dialysis Equipment In France
    • 11.1 Renal Dialysis Equipment Overall Revenue (2000-2015)
      • 11.1.1 Dialysis Accessories Overall Revenue (2000-2015)
    • 11.2 Renal Dialysis Equipment Overall Volume (2000-2015)
      • 11.2.1 Dialysis Accessories Overall Volume (2000-2015)
    • 11.3 Renal Dialysis Equipment Average Price (2000-2015)
    • 11.4 Renal Dialysis Equipment Distribution Share (2007-2008)
    • 11.5 Renal Dialysis Equipment, France, Company Share (2006-2007)
  • 12 Overview of Key Companies in France Nephrology and Urology Devices Market
    • 12.1 Svenska Celullosa Aktiebolaget SCA Company Profile
      • 12.1.1 Company Overview
    • 12.2 Fresenius Medical Care AG & Co. KGaA Company Profile
      • 12.2.1 Company Overview
      • 12.2.2 Value Chain Analysis
        • 12.2.2.1 Manufacturing
        • 12.2.2.2 Product Development
        • 12.2.2.3 Sales and Marketing
    • 12.3 Gambro AB Company Profile
      • 12.3.1 Company Overview
      • 12.3.2 Value Chain Analysis
        • 12.3.2.1 Manufacturing
        • 12.3.2.2 Product Development
        • 12.3.2.3 Sales and Marketing
      • 12.3.3 Gambro AB Pipeline Products
        • 12.3.3.1 Gambro AB Pipeline Products By Equipment Type
        • 12.3.3.2 Gambro AB Pipeline Products By Development Stage
        • 12.3.3.3 Gambro AB Pipeline Products By Therapy Area
        • 12.3.3.4 Gambro AB Pipeline Products By Clinical Trials
    • 12.4 Kimberly-Clark Corporation Company Profile
      • 12.4.1 Company Overview
      • 12.4.2 Value Chain Analysis
        • 12.4.2.1 Manufacturing
        • 12.4.2.2 Product Development
        • 12.4.2.3 Sales and Marketing
    • 12.5 HARTMANN GROUP Company Profile
      • 12.5.1 Company Overview
      • 12.5.2 Value Chain Analysis
        • 12.5.2.1 Manufacturing
        • 12.5.2.2 Product Development
        • 12.5.2.3 Sales and Marketing
    • 12.6 Coloplast A/S Company Profile
      • 12.6.1 Company Overview
      • 12.6.2 Value Chain Analysis
        • 12.6.2.1 Manufacturing
        • 12.6.2.2 Product Development
        • 12.6.2.3 Sales and Marketing
    • 12.7 Baxter International Inc. Company Profile
      • 12.7.1 Company Overview
      • 12.7.2 Value Chain Analysis
        • 12.7.2.1 Manufacturing
        • 12.7.2.2 Product Development
        • 12.7.2.3 Sales and Marketing
      • 12.7.3 Baxter International Inc. Pipeline Products
        • 12.7.3.1 Baxter International Inc. Pipeline Products By Equipment Type
        • 12.7.3.2 Baxter International Inc. Pipeline Products By Development Stage
        • 12.7.3.3 Baxter International Inc. Pipeline Products By Therapy Area
        • 12.7.3.4 Baxter International Inc. Pipeline Products By Clinical Trials
        • 12.7.3.5 Baxter International Inc. Pipeline Products By News Summary
    • 12.8 Teleflex Incorporated Company Profile
      • 12.8.1 Company Overview
      • 12.8.2 Value Chain Analysis
        • 12.8.2.1 Manufacturing
        • 12.8.2.2 Product Development
        • 12.8.2.3 Sales and Marketing
    • 12.9 STORZ MEDICAL AG Company Profile
      • 12.9.1 Company Overview
    • 12.10 Siemens Healthcare Company Profile
      • 12.10.1 Company Overview
      • 12.10.2 Value Chain Analysis
        • 12.10.2.1 Manufacturing
        • 12.10.2.2 Product Development
        • 12.10.2.3 Sales and Marketing
      • 12.10.3 Siemens Medical Solutions Pipeline Products
        • 12.10.3.1 Siemens Medical Solutions Pipeline Products By Equipment Type
        • 12.10.3.2 Siemens Medical Solutions Pipeline Products By Development Stage
        • 12.10.3.3 Siemens Medical Solutions Pipeline Products By Therapy Area
        • 12.10.3.4 Siemens Medical Solutions Pipeline Products By Clinical Trials
        • 12.10.3.5 Siemens Medical Solutions Pipeline Products By News Summary
    • 12.11 ONTEX International N.V. Company Profile
      • 12.11.1 Company Overview
    • 12.12 Dornier MedTech GmbH Company Profile
      • 12.12.1 Company Overview
    • 12.13 Covidien Ltd. Company Profile
      • 12.13.1 Company Overview
      • 12.13.2 Value Chain Analysis
        • 12.13.2.1 Manufacturing
        • 12.13.2.2 Product Development
        • 12.13.2.3 Sales and Marketing
    • 12.14 C.R. Bard, Inc. Company Profile
      • 12.14.1 Company Overview
      • 12.14.2 Value Chain Analysis
        • 12.14.2.1 Manufacturing
        • 12.14.2.2 Product Development
        • 12.14.2.3 Sales and Marketing
      • 12.14.3 C.R. Bard, Inc. Pipeline Products
        • 12.14.3.1 C.R. Bard, Inc. Pipeline Products By Equipment Type
        • 12.14.3.2 C.R. Bard, Inc. Pipeline Products By Development Stage
        • 12.14.3.3 C.R. Bard, Inc. Pipeline Products By Therapy Area
        • 12.14.3.4 C.R. Bard, Inc. Pipeline Products By Clinical Trials
    • 12.15 B. Braun Melsungen AG Company Profile
      • 12.15.1 Company Overview
      • 12.15.2 Value Chain Analysis
        • 12.15.2.1 Manufacturing
        • 12.15.2.2 Product Development
        • 12.15.2.3 Sales and Marketing
    • 12.16 AstraZeneca PLC Company Profile
      • 12.16.1 Company Overview
  • 13 Appendix
    • 13.1 Global Markets Direct Research Methodology
    • 13.2 Coverage
    • 13.3 Secondary Research
    • 13.4 Primary Research
    • 13.5 Models
    • 13.6 Forecasts
    • 13.7 Expert Panel Validation
    • 13.8 Currency Conversion
    • 13.9 Contact Us
    • 13.10 Disclaimer
  • 1 List of Tables
    • Table 1: Number of Doctors by Specialty in France, 2003-2007
    • Table 2: Number of Hospital Wards by Specialty in France, 2003-2007
    • Table 3: Nephrology and Urology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Table 4: Nephrology and Urology Devices, France, Overall Revenue ($ mn), 2000-2015
    • Table 5: Nephrology and Urology Devices, France, Cross-Category Analysis, 2000-2015
    • Table 6: Nephrology and Urology Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
    • Table 7: Nephrology and Urology Devices, France, Overall Revenue ($ mn), Forecast, 2008-2015
    • Table 8: Nephrology and Urology Devices, France, Category Volume (Units), 2000-2015
    • Table 9: Nephrology and Urology Devices, France, Category Volume (Units), Historic, 2000-2008
    • Table 10: Nephrology and Urology Devices, France, Category Volume (Units), Forecast, 2008-2015
    • Table 11: Nephrology and Urology Devices, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 12: Incontinence Devices, France, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 13: Incontinence Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 14: Incontinence Devices, France, Volume (Units), Historic, 2000-2008
    • Table 15: Incontinence Devices, France, Volume (Units), Forecast, 2008-2015
    • Table 16: Incontinence Devices, France, Average Price ($), Historic, 2000-2008
    • Table 17: Incontinence Devices, France, Average Price ($), Forecast, 2008-2015
    • Table 18: Incontinence Devices, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 19: Incontinence Devices, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 20: Lithotripters, France, Revenue ($ mn), Historic, 2000-2008
    • Table 21: Lithotripters, France, Revenue ($ mn), Forecast, 2008-2015
    • Table 22: Lithotripters, France, Volume (Units), Historic, 2000-2008
    • Table 23: Lithotripters, France, Volume (Units), Forecast, 2008-2015
    • Table 24: Lithotripters, France, Average Price ($), Historic, 2000-2008
    • Table 25: Lithotripters, France, Average Price ($), Forecast, 2008-2015
    • Table 26: Lithotripters, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 27: Lithotripters, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 28: Renal Dialysis Equipment, France, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Table 29: Renal Dialysis Equipment, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Table 30: Dialysis Accessories, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Table 31: Dialysis Accessories, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Table 32: Renal Dialysis Equipment, France, Volume (Units), Historic, 2000-2008
    • Table 33: Renal Dialysis Equipment, France, Volume (Units), Forecast, 2008-2015
    • Table 34: Dialysis Accessories, France, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Table 35: Dialysis Accessories, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Table 36: Renal Dialysis Equipment, France, Average Price ($), Historic, 2000-2008
    • Table 37: Renal Dialysis Equipment, France, Average Price ($), Forecast, 2008-2015
    • Table 38: Renal Dialysis Equipment, France, Distribution Share by Revenue ($mn), 2007-2008
    • Table 39: Renal Dialysis Equipment, France, Company Share by Revenue ($ mn), 2006-2007
    • Table 40: Gambro AB Pipeline Products by Equipment Type
    • Table 41: Gambro AB Pipeline Products By Development Stage
    • Table 42: Gambro AB Pipeline Products By Therapy Area
    • Table 43: Gambro AB Pipeline Products By Clinical Trials
    • Table 44: Baxter International Inc. Pipeline Products by Equipment Type
    • Table 45: Baxter International Inc. Pipeline Products By Development Stage
    • Table 46: Baxter International Inc. Pipeline Products By Therapy Area
    • Table 47: Baxter International Inc. Pipeline Products By Clinical Trials
    • Table 48: Baxter International Inc. Pipeline Products By News Summary
    • Table 49: Siemens Medical Solutions Pipeline Products by Equipment Type
    • Table 50: Siemens Medical Solutions Pipeline Products By Development Stage
    • Table 51: Siemens Medical Solutions Pipeline Products By Therapy Area
    • Table 52: Siemens Medical Solutions Pipeline Products By Clinical Trials
    • Table 53: Siemens Medical Solutions Pipeline Products By News Summary
    • Table 54: C.R. Bard, Inc. Pipeline Products by Equipment Type
    • Table 55: C.R. Bard, Inc. Pipeline Products By Development Stage
    • Table 56: C.R. Bard, Inc. Pipeline Products By Therapy Area
    • Table 57: C.R. Bard, Inc. Pipeline Products By Clinical Trials
    • Table 58: USD to Local Currency, Average Exchange Rate 2008
  • 1.2 List of Figures
    • Figure 1: Total Healthcare Expenditure in France, 2000 2006
    • Figure 2: Flowchart for Classification of Non-invasive Devices in France, 2007
    • Figure 3: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 4: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 5: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 6: Flowchart for Classification of Invasive Devices in France, 2007
    • Figure 7: Flowchart for Classification of Active Devices in France, 2007
    • Figure 8: Flowchart for Classification of Active Devices in France, 2007
    • Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in France, 2007
    • Figure 10: Conformity Assessment of Class-I Medical Devices in France, 2007
    • Figure 11: Conformity Assessment of Class-IIa Medical Devices in France, 2007
    • Figure 12: Conformity Assessment of Class-IIb Medical Devices in France, 2007
    • Figure 13: Conformity Assessment of Class-III Medical Devices in France, 2007
    • Figure 14: Medical Equipment Distribution Structure in France, 2007
    • Figure 15: Nephrology and Urology Devices Cross Country Comparison, Revenue ($ mn), 2000-2015
    • Figure 16: Nephrology and Urology Devices, France, Overall Revenue ($ mn), 2000-2015
    • Figure 17: Nephrology and Urology Devices, France, Cross-Category Analysis, 2000-2015
    • Figure 18: Nephrology and Urology Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
    • Figure 19: Nephrology and Urology Devices, France, Overall Revenue ($ mn), Forecast, 2008-2015
    • Figure 20: Nephrology and Urology Devices, France, Company Share (%), 2007
    • Figure 21: Incontinence Devices, France, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 22: Incontinence Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 23: Incontinence Devices, France, Volume (Units), Historic, 2000-2008
    • Figure 24: Incontinence Devices, France, Volume (Units), Forecast, 2008-2015
    • Figure 25: Incontinence Devices, France, Company Share (%), 2007
    • Figure 26: Lithotripters, France, Revenue ($ mn), Historic, 2000-2008
    • Figure 27: Lithotripters, France, Revenue ($ mn), Forecast, 2008-2015
    • Figure 28: Lithotripters, France, Volume (Units), Historic, 2000-2008
    • Figure 29: Lithotripters, France, Volume (Units), Forecast, 2008-2015
    • Figure 30: Lithotripters, France, Company Share (%), 2007
    • Figure 31: Renal Dialysis Equipment, France, Revenue ($ mn) by Segment, Historic, 2000-2008
    • Figure 32: Renal Dialysis Equipment, France, Revenue ($ mn) by Segment, Forecast, 2008-2015
    • Figure 33: Dialysis Accessories, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008
    • Figure 34: Dialysis Accessories, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
    • Figure 35: Dialysis Accessories, France, Volume (Units) by Sub-Segment, Historic, 2000-2008
    • Figure 36: Dialysis Accessories, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015
    • Figure 37: Renal Dialysis Equipment, France, Company Share (%), 2007
    • Figure 38: Fresenius Medical Care AG & Co. KGaA Value Chain Analysis
    • Figure 39: Gambro AB Value Chain Analysis
    • Figure 40: Kimberly-Clark Corporation Value Chain Analysis
    • Figure 41: Hartmann Group Value Chain Analysis
    • Figure 42: Coloplast A/S Value Chain Analysis
    • Figure 43: Baxter International Inc. Value Chain Analysis
    • Figure 44: Teleflex Incorporated Value Chain Analysis
    • Figure 45: Siemens Medical Solutions Value Chain Analysis
    • Figure 46: Covidien Ltd./Tyco Healthcare Value Chain Analysis
    • Figure 47: C.R. Bard, Inc. Value Chain Analysis
    • Figure 48: B. Braun Melsungen AG Value Chain Analysis
    • Figure 49: Global Markets Direct Methodology
Ask a question about this product

Ask a question about France Nephrology and Urology Devices Investment Opportunities

Enter the characters you see in the picture below
Captcha